<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02598765</url>
  </required_header>
  <id_info>
    <org_study_id>15-16075</org_study_id>
    <nct_id>NCT02598765</nct_id>
  </id_info>
  <brief_title>Micro vs. Standard Trabeculectomy Study</brief_title>
  <official_title>Micro vs. Standard Trabeculectomy Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Francis I. Proctor Foundation</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Seva Foundation</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Lumbini Eye Institute and Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Francis I. Proctor Foundation</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the reduction in intraocular pressure and
      cumulative incidence of complications between the standard and micro trabeculectomy surgeries
      3 months after surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a randomized, double-masked (study participants and outcome assessors) trial.
      During the enrollment period, consecutive patients from LEI who are planning to have
      trabeculectomy surgery and who meet the study enrollment criteria will be randomized to
      receive standard trabeculectomy or microtrabeculectomy. The primary outcome is complications
      and change in intraocular pressure after a 3 month follow-up period. We will perform subgroup
      analyses by stratifying the population according to skin pigmentation to determine whether
      pigmentation is a predictor of treatment success.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2016</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative incidence of complications</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Comparison of the cumulative incidence of complications between the treatment groups (regular and micro trabeculectomy) 3 months after surgery</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reduction in intraocular pressure</measure>
    <time_frame>3 months after surgery</time_frame>
    <description>Comparison of the reduction in intraocular pressure between the treatment groups (regular and micro trabeculectomy) 3 months after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cumulative incidence of complications</measure>
    <time_frame>6 and 12 months after surgery</time_frame>
    <description>Cumulative incidence of complications 6 months and 12 months after surgery will be compared between the treatment groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction of intraocular pressure</measure>
    <time_frame>6 and 12 months after surgery</time_frame>
    <description>Reduction of intraocular pressure 6 months and 12 months after surgery will be compared between the treatment groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">240</enrollment>
  <condition>Glaucoma</condition>
  <arm_group>
    <arm_group_label>Standard Trabeculectomy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients in the Standard Trabeculectomy arm will undergo regular trabeculectomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microtrabeculectomy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients in the Microtrabeculectomy arm will undergo microtrabeculectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard Trabeculectomy</intervention_name>
    <description>Fornix-based trabeculectomy with a 3x4 mm scleral flap.</description>
    <arm_group_label>Standard Trabeculectomy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Microtrabeculectomy</intervention_name>
    <description>Fornix-based trabeculectomy with a 2x2 mm scleral flap.</description>
    <arm_group_label>Microtrabeculectomy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt;= 40

          -  Planning to have a trabeculectomy

        Exclusion Criteria:

          -  Life threatening or debilitating disease

          -  Inability to complete necessary exams and/or ocular disease that would preclude
             assessment of intraocular pressure, visual field, or optic disc

          -  Contralateral eye already enrolled in study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeremy D Keenan, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>F. I. Proctor Foundation, UCSF</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeremy D Keenan, MD, MPH</last_name>
    <phone>415-476-6323</phone>
    <email>Jeremy.Keenan@ucsf.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Caitlin Moe, MS</last_name>
    <phone>415-502-2665</phone>
    <email>Caitlin.Moe@ucsf.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lumbini Eye Institute, Nepal</name>
      <address>
        <city>Siddharthanagar</city>
        <country>Nepal</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nanda Gurung, MD</last_name>
      <phone>00977-71-523827</phone>
      <email>gurungn55@yahoo.com</email>
    </contact>
    <investigator>
      <last_name>Nanda Gurung, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Nepal</country>
  </location_countries>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 4, 2015</study_first_submitted>
  <study_first_submitted_qc>November 4, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 6, 2015</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Francis I. Proctor Foundation</investigator_affiliation>
    <investigator_full_name>Jeremy Keenan</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Glaucoma</keyword>
  <keyword>Trabeculectomy</keyword>
  <keyword>Eye Disease</keyword>
  <keyword>Intraocular Pressure</keyword>
  <keyword>Visual Acuity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glaucoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

